Related Experiment Video
Updated: May 17, 2026
05:30
Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
Progesterone for acute traumatic brain injury.
Junpeng Ma1, Siqing Huang, Shu Qin
1Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.
The Cochrane Database of Systematic Reviews
|October 19, 2012
Summary
Progesterone may reduce mortality and severe disability in traumatic brain injury (TBI) patients. However, more multicenter randomized controlled trials are needed to confirm these findings for TBI treatment.
Area of Science:
- Neuroscience
- Clinical Medicine
- Pharmacology
Background:
- Traumatic brain injury (TBI) is a significant cause of mortality and long-term disability.
- Progesterone is being investigated as a potential neuroprotective agent for TBI treatment.
Purpose of the Study:
- To evaluate the efficacy and safety of progesterone in individuals with acute TBI.
- To synthesize evidence from randomized controlled trials (RCTs) on progesterone for TBI.
Main Methods:
- Comprehensive literature search across multiple databases (e.g., Cochrane, MEDLINE, EMBASE) up to August 2012.
- Inclusion of published and unpublished RCTs comparing progesterone with placebo or no progesterone in acute TBI patients.
- Independent screening and selection of studies by two reviewers to ensure accuracy.
Main Results:
- Three RCTs with 315 participants were included. Two studies were of high methodological quality.
- Progesterone administration showed a reduced risk ratio (RR) for mortality (0.61, 95% CI 0.40-0.93).
- A reduced RR for death or severe disability was observed (0.77, 95% CI 0.62-0.96); no significant differences in intracranial pressure or adverse events were found.
Conclusions:
- Preliminary evidence from three small RCTs suggests progesterone may improve neurological outcomes in TBI patients.
- The current evidence is limited, underscoring the need for larger, multicenter RCTs to validate these findings.
- Further research is essential to establish the role of progesterone in TBI management.
Related Concept Videos
01:28Traumatic Brain Injury l: Introduction
DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
01:14Increased Intracranial Pressure l: Introduction
Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...